Results 21 to 30 of about 54,991 (287)

Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women

Pharmaceuticals, 2022
For the first time, the present study employed hair testing to investigate the prevalence of classical drugs of abuse and new psychoactive substances use during gestation in a cohort of 300 Mexican pregnant women.
Larissa-María Gómez-Ruiz, Emilia Marchei, Maria Concetta Rotolo, Pietro Brunetti, Giulio Mannocchi, Aracely Acosta-López, Ruth-Yesica Ramos-Gutiérrez, Mary-Buhya Varela-Busaka, Simona Pichini, Oscar Garcia-Algar   +9 more
doaj   +1 more source

Computer-Aided Classification of New Psychoactive Substances

Journal of Chemistry, 2021
The appearance on the free market of synthetic cannabinoids raised the researchers’ interest in establishing their molecular similarity by QSAR analysis. A rigorous criterion for classifying drugs is their chemical structure.
Alina Bărbulescu, Lucica Barbeș, Cristian-Ştefan Dumitriu   +2 more
doaj   +1 more source

Herbal highs: review on psychoactive effects and neuropharmacology [PDF]

, 2017
Background: A new trend among users of new psychoactive substances’ the consumption of “herbal highs”: plant parts containing psychoactive substances.
Graziano, S, Orsolini, L, Pichini, S., Rotolo, Mc, Schifano, F, Tittarelli, R   +5 more
core   +1 more source

Similarities and differences in changing NPS market brought by new regulatory approaches in selected Eastern and Central European states with mostly focus on Poland and Latvia

Journal of Geography, Politics and Society, 2019
The main objective of the paper is to explain, compare and conclude the effect on the new psychoactive substances (NPS) market brought by new and innovative responses to regulate the NPS (mostly between 2010 and 2014) in Estonia, Latvia, Lithuania ...
Artur Malczewski , Agnese Zīle-Veisberga   +1 more
doaj   +1 more source

Update on Critical Issues and Current Challenges with “Newer Psychoactive Substances: An Narrative Review”

Indian Journal of Psychiatric Nursing, 2022
In recent years, new psychoactive substances (NPS) (”legal highs” or “designer drugs”) are increasing worldwide. An increase in NPS is a cause for concern for drug-regulatory authorities and health-care professionals as it poses a threat to public health.
Raka Jain, Kamini Verma
doaj   +1 more source

Experimental versus theoretical log D_7.4, pK_a and plasma protein binding values for benzodiazepines appearing as new psychoactive substances [PDF]

, 2018
The misuse of benzodiazepines as new psychoactive substances is an increasing problem around the world. Basic physicochemical and pharmacokinetic data is required on these substances in order to interpret and predict their effects upon humans ...
Manchester, Kieran R., Maskell, Peter D., Waters, Laura   +2 more
core   +2 more sources

New Psychoactive Substances: A Matter of Time [PDF]

Current Neuropharmacology, 2019
In the last few years, a wide range of new psychoactive substances (NPS) have been produced and marketed to elude the controlled substance lists. These molecules enter the traditional illegal and web market with poor knowledge about their toxicity, mechanism of action, metabolism, abuse potential so that they are directly tested by the consumers.
Pantano, Flaminia, Graziano, Silvia, Pacifici, Roberta, Busardò, Francesco Paolo, Pichini, Simona   +4 more
openaire   +2 more sources

Characteristics of psychiatric inpatients diagnosed with mental and behavioral disorders caused by psychoactive substances (F11-19 block), with a focus on NPS and psychiatric co-morbidities

International Journal of Occupational Medicine and Environmental Health, 2020
Objectives This study analyzed the prevalence of new psychoactive substance (NPS) use in the analyzed group and compared demographic features and psychoactive substance profiles between the 2 subgroups (NPS users, non-NPS users).
Piotr Engelgardt, Maciej Krzyżanowski, Przemysław Piotrowski, Małgorzata Borkowska-Sztachańska, Agnieszka Wasilewska, Tomasz Kowalkowski   +5 more
doaj   +1 more source

Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones

Biomedicines, 2022
In the recent decade, numerous new psychoactive substances (NPSs) have been added to the illicit drug market. These are synthetized to mimic the effects of classic drugs of abuse (i.e., cannabis, cocaine, etc.), with the purpose of bypassing substance ...
Leila Mazdai, Matteo Fabbri, Micaela Tirri, Giorgia Corli, Raffaella Arfè, Beatrice Marchetti, Sabrine Bilel, Eva Bergamin, Rosa Maria Gaudio, Michele Rubini, Fabio De-Giorgio, Matteo Marti   +11 more
doaj   +1 more source

The bridge between classical and ‘synthetic’/chemical psychoses: towards a clinical, psychopathological and therapeutic perspective [PDF]

, 2019
© 2019 Orsolini, Chiappini, Papanti, De Berardis, Corkery and Schifano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
Chiappini, Stephania, Corkery, John Martin, De Berardis, Domenico, Orsolini, Laura, Papanti, Duccio, Schifano, Fabrizio   +5 more
core   +2 more sources